The data displays the estimated market size for cancer biomarkers in the U.S. from 2015 to 2024, measured in billion USD. In 2015, the cancer biomarkers market in the United States was valued around 3.5 billion USD, of which 0.7 billion dollars were in the area of personalized medicine.
2015 | 0.5 | 0.7 | 1.3 | 1 |
2016 | 0.6 | 0.8 | 1.4 | 1.1 |
2017 | 0.7 | 0.9 | 1.6 | 1.2 |
2018 | 0.8 | 1 | 1.7 | 1.4 |
2019 | 0.8 | 1.2 | 1.9 | 1.6 |
2020 | 0.9 | 1.4 | 2.2 | 1.8 |
2021 | 1 | 1.6 | 2.4 | 2.1 |
2022 | 1.1 | 1.8 | 2.8 | 2.4 |
2023 | 1.3 | 2.1 | 3.1 | 2.8 |
2024 | 1.5 | 2.4 | 3.5 | 3.2 |